doi:10.3969/j.issn.1004-583X.2023.01.013

Abstract

CLC Number:

R587.1

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2023.01.013

https://huicui.hebmu.edu.cn/EN/Y2023/V38/I1/79

References 40

[1]	Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183:109119. doi: 10.1016/j.diabres.2021.109119 URL
[2]	White NH, Pan Q, Knowler WC, et al. Risk factors for the development of retinopathy in prediabetes and type 2 diabetes: The diabetes prevention program experience[J]. Diabetes Care, 2022, 45(11):2653-2661. doi: 10.2337/dc22-0860 pmid: 36098658
[3]	Sharma G, Ashhar MU, Aeri V, et al. Development and characterization of late-stage diabetes mellitus and -associated vascular complications[J]. Life Sci, 2019, 216: 295-304. doi: S0024-3205(18)30710-0 pmid: 30408473
[4]	Aoyama T, Sawamura T, Furutani Y, et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene[J]. Biochem J, 1999, 339(Pt 1):177-184. doi: 10.1042/bj3390177 URL
[5]	Jin P, Cong S. LOX-1 and atherosclerotic-related diseases[J]. Clin Chim Acta, 2019, 491:24-29. doi: S0009-8981(19)30019-1 pmid: 30639239
[6]	de Alwis N, Beard S, Binder NK, et al. LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblast[J]. Pregnancy Hypertens, 2021, 25:255-261. doi: 10.1016/j.preghy.2021.07.243 pmid: 34325289
[7]	Stankova TR, Delcheva GT, Maneva AI, et al. Serum levels of carbamylated LDL, nitrotyrosine and soluble lectin-like oxidized low-density lipoprotein receptor-1 in poorly controlled type 2 diabetes mellitus[J]. Folia Med (Plovdiv), 2019, 61(3): 419-425. doi: 10.3897/folmed.61.e39343 pmid: 32337929
[8]	Ackermann K, Bonaterra GA, Kinscherf R, et al. Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macropha ges[J]. Atherosclerosis, 2019, 281:128-136. doi: S0021-9150(18)31540-5 pmid: 30658188
[9]	Díaz-Ruiz M, Martínez-Triguero ML, López-Ruiz A, et al. Metabolic disorders and inflammation are associated with familial combined hyperlipemia[J]. Clin Chim Acta, 2019, 490:194-199. doi: S0009-8981(18)30486-8 pmid: 30201373
[10]	Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes[J]. N Engl J Med, 2018, 379 (7):633-644. doi: 10.1056/NEJMoa1800256 URL
[11]	GRADE Study Research Group, Nathan DM, Lachin JM, et al. Glycemia reduction in type 2 diabetes-microvascular and cardiovascular outcomes[J]. N Engl J Med, 2022, 387(12):1075-1088. doi: 10.1056/NEJMoa2200436 URL
[12]	Fazlali M, Kharazmi F, Kamran M, et al. Effect of oral magnesium sulfate administration on lectin-like oxidized low-density lipoprotein receptor-1 gene expression to prevent atherosclerosis in diabetic rat vessels[J]. J Diabetes Inve stig, 2019, 10(3):650-658.
[13]	Qian W, Cai X, Qian Q, et al. Astragaloside IV protects endothelial proge nitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway[J]. Drug Des Devel Ther, 2019, 13: 2579-2589. doi: 10.2147/DDDT.S207774 URL
[14]	Tiong YL, Ng KY, Koh RY, et al. Melatonin inhibits high glucose-induced ox-LDL/LDL expression and apoptosis in human umbilical endothelial cells[J]. Horm Mol Biol Clin Investig, 2020, 41(4).
[15]	Mortazavi-Jahromi SS, Alizadeh S, Javanbakht MH, et al. Cardioprotective ef fect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model[J]. Immunopharmacol Imm unotoxicol, 2018, 40(4):284-289.
[16]	Abbasnezhad A, Niazmand S, Mahmoudabady M, et al. Nigella sativa L. seed regulated eNOS, VCAM-1 and LOX-1 genes expression and improved vasoreactivity in aorta of diabetic rat[J]. J Ethnopharmacol, 2019, 228:142-147. doi: S0378-8741(18)30582-8 pmid: 30223051
[17]	Marshall SM. The pancreas in health and in diabetes[J]. Diabetologia, 2020, 63(10):1962-1965. doi: 10.1007/s00125-020-05235-z pmid: 32894305
[18]	Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, et al. Cellular death, reactive oxygen species (ROS) and diabetic complications[J]. Cell Death Dis, 2018, 9(2): 119. doi: 10.1038/s41419-017-0135-z pmid: 29371661
[19]	Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas[J]. Physiol Res, 2001, 50(6):537-546. pmid: 11829314
[20]	Xu K, Liu X, Yin D, et al. PP2A alleviates oxidized LDL-induced endothelial dysfunction by regulating LOX-1/ROS/MAPK axis[J]. Life Sci, 2020, 243:11 7270.
[21]	Bayatpoor ME, Mirzaee S, Karami Abd M, et al. Crocin treatment decreased pancreatic atrophy, LOX-1 and RAGE mRNA expression of pancreas tissue in chol esterol-fed and streptozotocin-induced diabetic rats[J]. J Complement Integr Med, 2019, 17(2): /j/jcim. 2020.17. issue-2/jcim-2019-0117/jcim-2019-0117. xml.
[22]	Islam J, Lee HJ, Yang SH, et al. Expansion of myeloid-derived suppressor cells correlates with renal progression in type 2 diabetic nephropathy[J]. Immune Netw, 2020, 20(2): e18. doi: 10.4110/in.2020.20.e18 URL
[23]	Roumeliotis S, Roumeliotis A, Georgianos PI, et al. Oxidized LDL is associated with eGFR decline in proteinuric diabetic kidney disease: A cohort study[J]. Oxid Med Cell Longev, 2021, 2021:2968869.
[24]	Zhou X, Liu R, Duan S, et al. High glucose enhances oxLDL-induced apoptosis in human renal proximal tubular epithelial cells largely via inducing lectin-like ox-LDL receptor-1[J]. Pharmacology, 2016, 98(1-2):20-28. doi: 10.1159/000444934 pmid: 27003929
[25]	郭亚玲, 陈卫东, 杨萍, 等. LOX-1、VCAM-1在糖尿病肾病动脉粥样硬化大鼠中的表达及普罗布考的影响[J]. 国际泌尿系统杂志, 2014, 34(2):177-183.
[26]	宋光明, 柴可夫, 杜月光. LOX-1和炎症因子在糖尿病肾病中的作用及糖肾颗粒早期干预研究[J]. 内蒙古中医药, 2016, 35(1):137-139.
[27]	杜月光, 钱俊文, 宋光明, 等. LOX-1在2型糖尿病大鼠肾小管间质中的表达及其意义[J]. 中国病理生理杂志, 2013, 29(1):50-55.
[28]	Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)[J]. J Diabetes Res, 2020, 2020:3920196.
[29]	Heidari F, Rabizadeh S, Mansournia MA, et al. Inflammatory, oxidative stress and anti-oxidative markers in patients with endometrial carcinoma and diabetes[J]. Cytokine, 2019, 120:186-190. doi: S1043-4666(19)30122-X pmid: 31100682
[30]	Ma S, Bai Z, Wu H, et al. The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB[J]. Eur J Pharmacol, 2019, 851:186-193. doi: S0014-2999(19)30016-0 pmid: 30639312
[31]	胡丽叶, 宋光耀, 朱旅云, 等. 2型糖尿病大鼠肝脏LOX-1、eNOS、PPARγ蛋白表达及罗格列酮的干预作用[J]. 临床误诊误治, 2015, 28(6):109-113.
[32]	Chen CM, Juan SH, Pai MH, et al. Hyperglycemia induces epithelial-mesenchymal transition in the lungs of experimental diabetes mellitus[J]. Acta Histochem, 2018, 120(6):525-533. doi: 10.1016/j.acthis.2018.06.004 URL
[33]	Korkmaz FT, Shenoy AT, Symer EM, et al. Lectin-like oxidized low-density lipoprotein receptor 1 attenuates pneumonia-induced lung injury[J]. JCI Insight, 2022, 7(23): e149955. doi: 10.1172/jci.insight.149955 URL
[34]	Hu C, Dandapat A, Sun L, et al. Regulation of TGFbeta1-mediated collagen formation by LOX-1: Studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts[J]. J Biol Chem, 2008, 283(16):10226-10231. doi: 10.1074/jbc.M708820200 pmid: 18182394
[35]	Zou XZ, Gong ZC, Liu T, et al. Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/ TGF-β1/KLF6 signaling pathway in diabetic pulmonary fibrosis[J]. Pulm Pharmacol Ther, 2017, 44:70-77. doi: 10.1016/j.pupt.2017.03.012 URL
[36]	El-Wakeel LM, Fouad FA, Saleem MD, et al. Efficacy and tolerability of sildenafil/l-arginine combination relative to sildenafil alone in patients with organic erectile dysfunction[J]. Andrology, 2020, 8(1):143-147. doi: 10.1111/andr.12671 pmid: 31267684
[37]	Bajaj HS, Gerstein HC, Rao-Melacini P, et al. Erectile function in men with type 2 diabetes treated with dulaglutide: An exploratory analysis of the REWIND placebo-controlled randomised trial[J]. Lancet Diabetes Endocrinol, 2021, 9 (8):484-490. doi: 10.1016/S2213-8587(21)00115-7 URL
[38]	杨志刚, 程宛钧, 谢瑜, 等. 丹瓜方联合枸橼酸西地那非片治疗痰瘀型2型糖尿病勃起功能障碍的临床观察[J]. 中西医结合研究, 2019, 11(2):93-95.
[39]	Wang JS, Li X, Chen ZL, et al. Effect of leech-centipede medicine on improving erectile function in DIED rats via PKC signalling pathway-related molecules[J]. J Ethnopharmacol, 2021, 267:113463. doi: 10.1016/j.jep.2020.113463 URL
[40]	Li X, Feng JL, Chen ZL, et al. Mechanism by which Huoxue Tongluo Qiwei Decoction improves the erectile function of rats with diabetic erectile dysfunction[J]. J Ethnopharmacol, 2022, 283:114674. doi: 10.1016/j.jep.2021.114674 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 40

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Lv Shasha, Song Jinlan, Shi Jian. Mitochondrial mutation m.3243A> G associated with diabetes mellitus: One case report and literature review [J]. Clinical Focus, 2024, 39(2): 160-163.
[2]	Zhang Jianan, Sun Linlin, Zhan Xiaoyan, Li Bing. Correlation between serum Vitamin B₁₂ and mild cognitive impairment in elderly patients with type 2 diabetes mellitus [J]. Clinical Focus, 2024, 39(1): 34-37.
[3]	Liao Kunfeng, Yao Yisong, Yang Jinpan, Yang Xining, Li Yaru, Zhou Hongyan, Liang Piao. Status and influencing factors of fear of progression in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(12): 1095-1100.
[4]	Shi Peihua, Lin Yanlin, Bi Lifang. Study on the correlation of NLR, PLR and MLR with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2023, 38(11): 996-1001.
[5]	Yang Xin, Xu Huajiao. Bibliometric analysis of literatures reporting psychological intervention of patients with diabetes mellitus: Based on Web of Science [J]. Clinical Focus, 2023, 38(8): 731-736.
[6]	Jin Jiahui, Yang Yang, Qin Tong, He Yuxin, Su Meihua. Probiotic supplementation on improving glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(7): 581-587.
[7]	Wu Yanan, Yan Tianmei, Liang Peng, Wei Limin. High-risk identification of depressive symptoms in middle-elderly patients with diabetes [J]. Clinical Focus, 2023, 38(6): 516-520.
[8]	Yang Minxing, Sun Lu, Ye Yun, Xu Wendong, Huang Xiaolin, Zhang Haiyun, Xu Yinglei. Characteristics of cognitive function and corresponding factors in young and middle-aged patients with type 2 diabetes with obstructive sleep apnea hypopnea syndrome [J]. Clinical Focus, 2023, 38(3): 216-220.
[9]	Rao Xiaojuan, Shi Shuangwei, Sang Yanhong. Comparison of short-term efficacy of insulin degludec/insulin versus continuous subcutaneous infusion of insulin asparton diabetic patients admitted in non-endocrinology departments [J]. Clinical Focus, 2023, 38(2): 132-136.
[10]	Xie Feifei, Zhang Weijian. Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A meta-analysis [J]. Clinical Focus, 2023, 38(1): 20-36.
[11]	Wang Cui, Lin Hao, Wu Pingping, Zhang Yali, Ren Jian, Xu Ting, Dong Guoyu, Zai Guotian. Correlation between hyperhomocysteinemia and early renal disease in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(1): 42-45.
[12]	Wang Runqing, Wang Qian, Liao Jianxiong. A network meta-analysis of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes [J]. Clinical Focus, 2022, 37(12): 1061-1073.
[13]	Wang Wenqi, Zhang Tao. Effect of semaglutide on total myocardial ischemic burden and serum inflammatory factors in patients with type 2 diabetes mellitus complicated with coronary heart disease [J]. Clinical Focus, 2022, 37(11): 996-1000.
[14]	. [J]. Clinical Focus, 2022, 37(10): 953-956.
[15]	Zhao Liyan, Kang wei, Wang Qingzhou, Li Bopeng, Cao Yawei, Li Junfen, Shao Liang, Wang Kang. Correlation analysis between lipid accumulation index and visceral fat index and glucose metabolism disorders in first-degree relatives of type 2 diabetes mellitus [J]. Clinical Focus, 2022, 37(9): 804-807.